Dallas VA Medical Center
Dallas, Texas, 75216, United States
NCT Number: NCT01892033
The overall aim of this pilot feasibility study is to determine if 12-week moderate intensity exercise can safely alleviate posttraumatic symptoms in premenopausal women veterans.
Specific aims of the study are to;
1. Determine the feasibility, safety, and tolerability of 12-week moderate intensity exercise 2. Explore potential therapeutic benefits of 12-week moderate intensity exercise. Outcome data will include posttraumatic and depressive symptoms. 3. Explore potential therapeutic effects of a 12-week moderate intensity exercise on comorbid pain syndrome and quality of life.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Dallas, Texas, 75216, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12 weeks of brisk walking
Time frame: Changes from baseline to week 12.
Time frame: Changes from baseline to week 12.
Time frame: Changes from baseline to week 12.
Time frame: Changes from baseline to week 12.
Time frame: Changes from baseline to week 12.
Time frame: 12 Weeks
North Texas Veterans Healthcare System
Fed
Aerobic Exercise: Feasibility and Safety Assessment in Women Veterans With PTSD (AESAP)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763681
COVID-19, Coronaviridae Infections
Toronto, Ontario, Canada
View Trial DetailsNCT05862467
Autism, Autism Spectrum Disorder
Laramie, Wyoming, United States
View Trial DetailsNCT06130501
Chemically-Induced Disorders, Mental Disorders
Cape Girardeau, Missouri, United States
View Trial DetailsNCT05280691
Anxiety Disorders, Behavior
Winterthur, Canton of Zurich, Switzerland
View Trial Details